Modulating the Blood-Brain Barrier: A Comprehensive Review

被引:41
作者
Whelan, Rory [1 ,2 ]
Hargaden, Grainne C. [3 ]
Knox, Andrew J. S. [1 ,2 ]
机构
[1] Tech Univ Dublin, Sch Biol & Hlth Sci, Dublin D07 XT95, Ireland
[2] Technol Univ Dublin, Environm Sustainabil & Hlth Inst, Chem & Struct Biol, Dublin D07 H6K8, Ireland
[3] Technol Univ Dublin, Sch Chem & Pharmaceut Sci, Dublin D07 XT95, Ireland
关键词
blood-brain barrier (BBB); CNS drug delivery; tight junction (TJ); BBB permeability; BBB modulation; focused ultrasound; intra-arterial drug delivery; hyperosmolar agents; glioblastoma; alzheimers; GUIDED FOCUSED ULTRASOUND; ZONULA-OCCLUDENS TOXIN; POSITRON-EMISSION-TOMOGRAPHY; ACUTE INFLAMMATORY RESPONSE; TIGHT JUNCTION MODULATION; GLIOMA-BEARING RATS; IN-VITRO; CHEMOTHERAPEUTIC-AGENTS; DRUG-DELIVERY; GENE DELIVERY;
D O I
10.3390/pharmaceutics13111980
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The highly secure blood-brain barrier (BBB) restricts drug access to the brain, limiting the molecular toolkit for treating central nervous system (CNS) diseases to small, lipophilic drugs. Development of a safe and effective BBB modulator would revolutionise the treatment of CNS diseases and future drug development in the area. Naturally, the field has garnered a great deal of attention, leading to a vast and diverse range of BBB modulators. In this review, we summarise and compare the various classes of BBB modulators developed over the last five decades-their recent advancements, advantages and disadvantages, while providing some insight into their future as BBB modulators.
引用
收藏
页数:54
相关论文
共 267 条
[71]   A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma [J].
Ford, J ;
Osborn, C ;
Barton, T ;
Bleehen, NM .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (11) :1807-1811
[72]   Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug [J].
Gaillard, PJ ;
de Boer, AG .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (02) :95-102
[73]   Melittin: A lytic peptide with anticancer properties [J].
Gajski, Goran ;
Garaj-Vrhovac, Vera .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2013, 36 (02) :697-705
[74]   Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma [J].
Galla, Naveen ;
Chiang, Gloria ;
Chakraborty, Shamik ;
Singh, Ranjodh ;
Tsiouris, A. John ;
Boockvar, John ;
Kovanlikaya, Ilhami .
NEURORADIOLOGY, 2017, 59 (05) :499-505
[75]   Protean agonism at histamine H3 receptors in vitro and in vivo [J].
Gbahou, F ;
Rouleau, A ;
Morisset, S ;
Parmentier, R ;
Crochet, S ;
Lin, JS ;
Ligneau, X ;
Tardivel-Lacombe, J ;
Stark, H ;
Schunack, W ;
Ganellin, CR ;
Schwartz, JC ;
Arrang, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :11086-11091
[76]   Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery [J].
Ghose, Arup K. ;
Herbertz, Torsten ;
Hudkins, Robert L. ;
Dorsey, Bruce D. ;
Mallamo, John P. .
ACS CHEMICAL NEUROSCIENCE, 2012, 3 (01) :50-68
[77]  
Godinho B.M., 2018, MOL THER, V26
[78]   Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization Assay [J].
Godinho, Bruno M. D. C. ;
Gilbert, James W. ;
Haraszti, Reka A. ;
Coles, Andrew H. ;
Biscans, Annabelle ;
Roux, Loic ;
Nikan, Mehran ;
Echeverria, Dimas ;
Hassler, Matthew ;
Khvorova, Anastasia .
NUCLEIC ACID THERAPEUTICS, 2017, 27 (06) :323-334
[79]   The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation [J].
Goldblum, Simeon E. ;
Rai, Usha ;
Tripathi, Amit ;
Thakar, Manjusha ;
De Leo, Luigina ;
Di Toro, Nicola ;
Not, Tarcisio ;
Ramachandran, Rithwik ;
Puche, Adam C. ;
Hollenberg, Morley D. ;
Fasano, Alessio .
FASEB JOURNAL, 2011, 25 (01) :144-158
[80]   Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier [J].
Gomes, Maria Joao ;
Kennedy, Patrick J. ;
Martins, Susana ;
Sarmento, Bruno .
NANOMEDICINE, 2017, 12 (12) :1385-1399